Breast cancer screening: can the iBreastExam bridge the gap?

Olaogun, Julius; Agodirin, Olayide

doi:10.1016/s2214-109x(22)00078-x

Cited by 5 publications

(5 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Predictors of screening include education level, increased age, having health insurance and high socioeconomic status [ 56 ]. The scarcity of mammography facilities has led to the consideration of using handheld breast cancer screening equipment, such as iBreast Exam [ 57 ].…”

Section: Editorialmentioning

confidence: 99%

From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa

Dlamini,

Molefi,

Khanyile

et al. 2023

Oncol Ther

View full text Add to dashboard Cite

The formidable impact of breast cancer extends globally, with South Africa facing pronounced challenges, including significant disparities in breast cancer screening, treatment and survival along ethnic and socioeconomic lines. Over the last two decades, breast cancer incidence has increased and now accounts for a substantial portion of cancers in women. Ethnic disparities in terms of screening, incidence and survival exacerbate the issue, leading to delayed diagnosis among Black patients and highlighting healthcare inequities. These concerning trends underscore the urgency of enhancing breast cancer screening while mitigating treatment delays, although obstacles within the healthcare system impede progress. The intersection of breast cancer and human immunodeficiency virus (HIV) further complicates matters and particularly affects the Black population. Tackling the aforementioned disparities in breast cancer in South Africa mandates a multifaceted strategy. Robust screening efforts, particularly those targeting marginalised communities, are crucial for early detection. Concurrently, expedited treatment initiation is imperative. Addressing HIV-related complexities requires tailored interventions to ensure effective care. These multifaceted disparities require pan African research and cooperation as well as tailored interventions to enhance breast cancer care within the African region.

show abstract

Section: Editorialmentioning

confidence: 99%

From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa

Dlamini,

Molefi,

Khanyile

et al. 2023

Oncol Ther

View full text Add to dashboard Cite

show abstract

“…Estimates in SSA show that the five-year survival rate is near or almost 50%, meaning that in every two women diagnosed with breast cancer, one will die within five years after diagnosis [ 3 ]. The poor survival rate is largely attributed to the advanced-stage diagnosis due to scarce diagnostic equipment, and lack of access to health care in SSA [ 4 – 6 ]. Approximately 80% of women who are diagnosed at the late stages appear in health facilities with locally advanced and metastatic disease in SSA [ 7 ].…”

Section: Introductionmentioning

confidence: 99%

Factors associated with the uptake of clinical breast examination among women of reproductive age in Lesotho: analysis of a national survey

et al. 2023

View full text Add to dashboard Cite

Background In low-resource settings with weak health systems, the WHO recommends clinical breast examination (CBE) as the most cost-effective breast screening modality for women. Evidence shows that biennial CBE leads to significant downstaging of breast cancer in all women. Breast cancer is the second most common cancer among women in Lesotho with a weaker healthcare system and a low breast cancer screening rate. This study investigated the prevalence and factors associated with the uptake of CBE among women of reproductive age in Lesotho. Methods This study used cross-sectional data from the 2014 Lesotho Demographic and Health Survey. A sample of 6584 reproductive-age women was included in this study. We conducted both descriptive and multivariable logistic regression analyses. The study results were presented in frequencies, percentages, and adjusted odds ratios (aOR) with their corresponding confidence intervals (CIs). Results The prevalence of CBE uptake was 9.73% (95% CI: 8.91, 10.61). Women who were covered by health insurance (aOR = 2.31, 95% CI [1.37, 3.88]), those who were pregnant (aOR = 2.34, 95% CI [1.64, 3.35]), those who had one to three children (aOR = 1.81, 95% CI [1.29,2.52]), and women who frequently read newspapers or magazines (aOR = 1.33, 95% CI [1.02,1.72]) were more likely to undergo CBE than their counterparts. Women who were aware of breast cancer (aOR = 2.54, 95% CI [1.63,3.97]), those who have ever had breast self-examination (BSE) within the last 12 months prior to the study (aOR = 5.30, 95% CI [4.35,6.46]), and those who visited the health facility in the last 12 months prior to the study (aOR = 1.57, 95% CI [1.27,1.95]) were also more likely to undergo CBE than their counterparts. Women residing in the Qacha’s-nek region (aOR = 0.42, 95% CI [0.26,0.67]) were less likely to undergo CBE than those in the Botha-bothe region. Conclusion The study found a low prevalence of CBE uptake among reproductive-age women in Lesotho. Factors associated with CBE uptake include health insurance coverage, being pregnant, those who had one to three children, exposure to media, breast cancer awareness, ever had BSE, and those who visited a health facility. To increase CBE uptake, these factors should be considered when designing cancer screening interventions and policies in order to help reduce the burden of breast cancer in Lesotho.

show abstract

“…In recent years, breast cancer has become the most common malignancy worldwide and seriously affects women's physical and mental health [1,2]. According to the latest report by the International Agency for Research on Cancer (IARC), breast cancer first exceeded the incidence of lung cancer and accounted for 11.7% of new cancer cases in 2020 [3].…”

Section: Introductionmentioning

confidence: 99%

Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis

Wang

Yang

et al. 2022

Cell Death Dis

View full text Add to dashboard Cite

Numerous studies have shown that circRNAs are aberrantly expressed in various cancers and play a significant role in tumor progression. However, the molecular mechanisms of circRNAs in triple-negative breast cancer (TNBC) remain ambiguous. By intersecting throughput data and qRT-PCR results from tissues and cell lines, circ-TRIO was identified as a potential oncogenic regulator of TNBC. Moreover, circ-TRIO expression was detected in TNBC tissues and was correlated with the recurrence and prognosis of TNBC patients. The circular characteristics of circ-TRIO were verified by RNase R and CHX assays. Functionally, the knockdown of circ-TRIO inhibited the proliferation, migration and invasion of TNBC cells, while the overexpression of circ-TRIO resulted in the opposite impacts. Mechanistically, a dual luciferase reporter assay and RNA immunoprecipitation were performed and indicated that circ-TRIO could combine with miR-432-5p to regulate the expression of coiled-coil domain containing 58 (CCDC58). In summary, our study illustrates that circ-TRIO plays an important role in the progression of TNBC by regulating the miR-432-5p/CCDC58 axis, which could broaden our insight into the underlying mechanisms and provide a novel prognostic marker of TNBC in the clinic.

show abstract

Breast cancer screening: can the iBreastExam bridge the gap?

Cited by 5 publications

References 10 publications

From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa

From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa

Factors associated with the uptake of clinical breast examination among women of reproductive age in Lesotho: analysis of a national survey

Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis

Contact Info

Product

Resources

About